Nicholas Hannah
Overview
Explore the profile of Nicholas Hannah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan N, Zampogna C, Lynch K, Hannah N, Sood S, Collins K, et al.
Aliment Pharmacol Ther
. 2025 Mar;
PMID: 40025830
Background And Aims: Primary sclerosing cholangitis (PSC) is a rare, cholestatic liver condition that has a significant association with inflammatory bowel disease (IBD) and impaired health-related quality of life (HRQOL)....
2.
Hannah N, Yu C, Nedumannil L, Haridy J, Kong G, Boussioutas A, et al.
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594820
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) is widely used in prostate cancer. Recent studies indicate hepatocellular carcinoma (HCC) demonstrates PSMA PET uptake. The diagnostic accuracy of PSMA PET...
3.
Abdelmalak J, Strasser S, Ngu N, Dennis C, Sinclair M, Majumdar A, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272868
Percutaneous ablation is recommended in Barcelona Clinic Liver Cancer (BCLC) stage 0/A patients with HCC ≤3 cm as a curative treatment modality alongside surgical resection and liver transplantation. However, trans-arterial...
4.
Abdelmalak J, Strasser S, Ngu N, Dennis C, Sinclair M, Majumdar A, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893086
The management of early-stage hepatocellular carcinoma (HCC) is complex, with multiple treatment strategies available. There is a paucity of literature regarding variations in the patterns of care and outcomes between...
5.
Tan N, Ngu N, Worland T, Lee T, Abrahams T, Freeman E, et al.
Hepatol Commun
. 2024 May;
8(5).
PMID: 38696372
Background: The benefits of regular surveillance imaging for cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC) are unclear. Hence, we aimed to evaluate the impact of regular magnetic resonance cholangiopancreatography...
6.
Abdelmalak J, Strasser S, Ngu N, Dennis C, Sinclair M, Majumdar A, et al.
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136287
The optimal treatment approach in very-early and early-stage hepatocellular carcinoma (HCC) is not precisely defined, and there is ambiguity in the literature around the comparative efficacy of surgical resection versus...
7.
Hannah N, Tjandra D, Patwardhan A, Rutland K, Halliday J, Sood S
JGH Open
. 2023 Aug;
7(8):537-544.
PMID: 37649856
Background And Aim: Long-term human albumin (HA) infusions improve survival in cirrhotic patients with diuretic resistant ascites. We aimed to determine whether there is a significant benefit in a more...
8.
Schneider D, Strathmore A, Yu C, Hannah N, Sood S
Aliment Pharmacol Ther
. 2023 Apr;
57(10):1210-1211.
PMID: 37094310
No abstract available.
9.
Hannah N, Vasic D, Kansal A, Al-Ani A, Hebbard G, Sood S
Intern Med J
. 2023 Mar;
53(11):2057-2064.
PMID: 36891668
Background: Hepatic encephalopathy is a confusional state associated with cirrhosis. Serum ammonia levels are neither sensitive nor specific for the diagnosis. Aims: We audited the ordering location and hospital unit...
10.
Bishop B, Hannah N, Doyle A, Amico F, Hockey B, Moore D, et al.
Aliment Pharmacol Ther
. 2019 Feb;
49(7):940-951.
PMID: 30761577
Background: Volatile anaesthetics are known to cause drug-induced liver injury, a hepatotoxic reaction characterised by antibodies to trifluoroacetylated lipid and protein adducts and cytochrome p450 2E1. The incidence of volatile...